Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Two-part, Dose-escalation and Comparative Pharmacokinetics Study of UB-921 in Healthy Male Volunteers

NCT03013881 is registered in ClinicalTrials.gov with United BioPharma as lead sponsor.

NCT NCT03013881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Two-part, Dose-escalation and Comparative Pharmacokinetics Study of UB-921 in Healthy Male Volunteers
Lead sponsor
United BioPharma
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2018
Completion date
April 2, 2019
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm